The seminar will feature presentations from a selection of leading Nordic healthcare companies, each addressing women’s health from their own perspective – including underlying biology, innovative medicines, clinical development programs, and ongoing & upcoming clinical trials. Hadean Ventures will be represented by an expert speaker who will elaborate on opportunities within women’s health.

Each participating company will provide a concise overview of their research focus, therapeutic approach, and progress within women’s health–related indications, followed by a brief Q&A.

Participating companies: Hadean Ventures, Gubra, Dilafor, Gesynta, Affibody, Oncoinvent, and Coloplast

Date: 16 March

Time: 14:00-16:00

Venue: Virtual

RSVP: contact your local ABGSC representative or Corporate Access Group at invitations@abgsc.no.

Please note that this event is for ABGSC clients only. For more information on how to become a client, send an e-mail to invitations@abgsc.no